Literature DB >> 18227488

Cardiovascular complications in diabetes: targets and interventions.

Alin O Stirban1, Diethelm Tschoepe.   

Abstract

Cardiovascular complications are mainly responsible for the high morbidity and mortality in people with diabetes. The awareness of physicians for the importance of primary prevention increased lately and numerous strategies have been developed. The spectrum ranges from pharmacologic treatment to vitamins and dietetic interventions. Some interesting concepts such as focusing on exogenous advanced glycation end products have emerged, but definitive results on their clinical relevance are still lacking. A major problem of the primary prevention is the choice of the method applied for screening, the criteria used to classify risk patients, as well as the choice of therapy. Guidelines provide goals to be achieved and offer alternatives for treatment, but the medical decision has to be made on an individualized basis. In this overview, we will comprehensively focus on the most important pathomechanisms and clinically relevant approaches, aiming at the early diagnosis and treatment of diabetes along with coronary heart disease. When primary prevention fails, we advocate a more aggressive treatment of critically ill patients, followed by optimal secondary prevention meeting on-target goals precisely.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18227488     DOI: 10.2337/dc08-s257

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  18 in total

1.  Impaired glucose tolerance plus hyperlipidaemia induced by diet promotes retina microaneurysms in New Zealand rabbits.

Authors:  Tatiana Helfenstein; Francisco A Fonseca; Sílvia S Ihara; Juliana M Bottós; Flávio T Moreira; Henrique Pott; Michel E Farah; Maria C Martins; Maria C Izar
Journal:  Int J Exp Pathol       Date:  2011-02       Impact factor: 1.925

Review 2.  The efficacy and safety of liraglutide.

Authors:  Kyeong-Hye Jeong; Bong Kyu Yoo
Journal:  Int J Clin Pharm       Date:  2011-09-28

3.  [Cardial target-organ damage in diabetes].

Authors:  W Motz; W Kerner
Journal:  Internist (Berl)       Date:  2011-05       Impact factor: 0.743

4.  [Characteristics of therapy of acute myocardial infarction in diabetes].

Authors:  W Motz; W Kerner
Journal:  Herz       Date:  2012-05       Impact factor: 1.443

5.  [ESC/EASD joint guidelines on diabetes and cardiovascular diseases].

Authors:  Wolfgang Motz; Rolf Dörr
Journal:  Herz       Date:  2009-02       Impact factor: 1.443

6.  Glycated hemoglobin and its spinoffs: Cardiovascular disease markers or risk factors?

Authors:  Jumana Saleh
Journal:  World J Cardiol       Date:  2015-08-26

Review 7.  Hopes, disillusions and more hopes from vitamin C.

Authors:  M C De Tullio; O Arrigoni
Journal:  Cell Mol Life Sci       Date:  2004-01       Impact factor: 9.261

8.  Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions.

Authors:  Dieter Schoepf; Hardeep Uppal; Rahul Potluri; Reinhard Heun
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-08-13       Impact factor: 5.270

9.  The antidiabetic effects of an herbal formula composed of Alnus hirsuta, Rosa davurica, Acanthopanax senticosus and Panax schinseng in the streptozotocin-induced diabetic rats.

Authors:  Weicheng Hu; Jin-Hee Yeo; Yunyao Jiang; Seong-Il Heo; Myeong-Hyeon Wang
Journal:  Nutr Res Pract       Date:  2013-04-01       Impact factor: 1.926

10.  Detectable subclinical myocardial necrosis is associated with cardiovascular risk in stable patients with diabetes.

Authors:  W H Wilson Tang; Yuping Wu; Earl B Britt; Naveed Iqbal; Stanley L Hazen
Journal:  Diabetes Care       Date:  2013-02-07       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.